Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Novartis To Pay $9.7bn For The Medicines Company
Bid Follows Strong Data For Twice-Yearly Gene Silencing Cholesterol Lowerer
Nov 25 2019
•
By
Eleanor Malone
Basel-based Novartis is acquiring The Medicines Company
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Deals
More from Business